UAE next generation sequencing market is
anticipated to grow at a robust CAGR during the forecast period, 2023-2027. The
increasing prevalence of cancer and the rise in the applications of next
generation sequencing in cancer treatment are the primary factors driving the
growth of the UAE next generation sequencing market.
Also, ongoing advancements
in next generation sequencing platforms and support from the government for
research and development activities are projected to play a significant role in
accelerating the market demand in the next five years.
Increasing Prevalence of Cancer Drives
the Market Growth
Cancer is one of the third leading
causes of death in the UAE after trauma and cardiovascular diseases. Cancer is
a type of heterogeneous disease and is caused due to accumulation of DNA
mutations. Next generation sequencing is increasingly adopted for cancer
genomic research owing to the improvement and development of new sequencing
technology.
It is used to advance the personalized treatment of cancer and
identify rare and novel cancer mutations. Next generation sequencing is
expected to significantly improve cancer diagnosis, treatment, and management
as it can sequence human genomes and thousands of cancer genomes. The process
helps to understand the molecular mechanism of oncogenesis and efficiently and
accurately identify high-risk patients and chemotherapeutic drugs to cure the
disease.
The government is focusing on improving
the healthcare sector and providing quality care to patients. In 2019, UAE
healthcare expenditure as a % of GDP was 4.27%. UAE has a solid economic
resource that can be utilized to improve cancer care across the country.
Emirates Oncology Society established a UAE Oncology Task Force in 2019 to
treat the growing number of cancer patients.
The rise in the adoption of
unhealthy eating habits and sedentary lifestyles by people is expected to fuel
the occurrence of cancer among patients. The increase in the use of
next-generation sequencing technology by the market players to enhance the
quality of care is expected to boost the growth of the UAE next-generation
sequencing market through the forecast period.
Support from the Government in Next
Generation Sequencing Technology
The UAE government is continuously
working on advancing the healthcare sector and providing quality care to all of
its citizens. Currently, the healthcare services for free for all UAE citizens.
Dubai Genetic center has extended its services and has added a genomics unit to
implement the next generation sequencing technology for better disease
diagnosis and treatment.
Also, the government has established a board of the
Emirati Genome Program and launched a Center for Genomic Discovery which is the
first of its kind to provide personalized and personal healthcare for the
Emirati population. The government's growing focus on improving the cancer
treatment facilities and services and allocating huge funds for cancer
treatment is expected to boost the UAE next generation sequencing market growth
for the next five years.
Technological Advancements in Next
Generation Sequencing Platforms
Market players are investing in research
and development activities to advance the existing infrastructure and find
novel solutions to improve the results of next generation sequencing. The
introduction of easy-to-use and portable next generation sequencing platforms
which can provide quick and accurate test results is in high demand.
Market
players have started to focus on enhancing the precision of results obtained
from next generation platforms and increasing the funds for research and
development activities which is expected to create lucrative growth
opportunities for UAE next generation sequencing market in the forecast period.
Click here to download the sample
Market Segmentation
The UAE next generation sequencing market
is segmented into product, technology, application, end user, regional
distribution, and company.
Based
on product, the market is divided into consumables, platforms, and services.
Based on technology, the market is divided into sequencing by synthesis, ion
semiconductor sequencing, sequencing by ligation, single molecule real time
sequencing, and others.
Based on application, the market is divided into biomarkers
& cancer, diagnostics, reproductive health, personalized medicine,
agriculture & animal research, and others.
Based on end user, the market is
divided into academic & clinical research centers, pharmaceutical &
biotechnology companies, hospitals & clinics, and others. To analyze
the market based on the region, the UAE next generation sequencing market is
studied in major regions namely Dubai, Abu Dhabi, Sharjah, and Rest of the UAE.
Market Players
Oxford Nanopore UAE, Agiomix Labs,
Illumina UAE, Thermo Fischer Scientific UAE, PerkinElmer UAE, Alliance Global
UAE, are among the major market players operating in the UAE next generation
sequencing market.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historic Data
|
2017 –
2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023
– 2027
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments covered
|
·
Product
·
Technology
·
Application
·
End User
|
|
Regional scope
|
Dubai,
Abu Dhabi, Sharjah, Rest of UAE
|
|
Key companies profiled
|
Oxford Nanopore UAE, Agiomix Labs, Illumina UAE, Thermo
Fischer Scientific UAE, PerkinElmer UAE, Alliance Global UAE
|
|
Customization scope
|
10%
free report customization with purchase. Addition or alteration to regional
& segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and
Excel through Email (We can also provide the editable version of the report
in PPT/Word format on special request)
|
Report Scope:
In this report, UAE next generation
sequencing market has been segmented into following categories, in addition to
the industry trends which have also been detailed below:
- UAE Next Generation Sequencing Market,
By Product:
- Consumables
- Platforms
- Services
- UAE Next Generation Sequencing Market, By Technology:
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Single Molecule Real Time
Sequencing
- Others
- UAE Next Generation Sequencing Market, By Application:
- Biomarkers & Cancer
- Diagnostics
- Reproductive Health
- Personalized Medicine
- Agriculture & Animal Research
- Others
- UAE Next Generation Sequencing Market, By End User:
- Academic & Clinical Research Centers
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
- Others
- UAE Next Generation
Sequencing Market, By Region:
- Dubai
- Abu Dhabi
- Sharjah
- Rest of UAE
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in UAE next generation sequencing
market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
UAE next generation sequencing market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]